Assistant Professor of Medicine
NYU Grossman School of Medicine
New York, NY, United States
Dr. Angélica Cifuentes Kottkamp is a South American doctor who graduated in 2011 from San Martín University, in Bogotá D.C., Colombia. She came to the United States in 2012 to work as a Research Assistant at the Glomerular Center of Columbia University where she oversaw multiple clinical trials on glomerular diseases and kidney transplant. She completed her residency in Internal Medicine in BronxCare Health System, an affiliated hospital of Icahn School of Medicine, and in 2016 joined NYU Grossman School of Medicine where she completed her Fellowship in Infectious Diseases and Immunology. She joined the Division as Faculty in 2018 and became a key member of the Bellevue Hospital ID faculty where she takes care of patients living with HIV, mostly Hispanic/Latinx at the Virology Clinic. Dr. Kottkamp has led basic science research on Zika and Chikungunya virus, and has been a major educator in the training of ID specialists both at NYU and internationally in Zambia & Ghana. In 2019 she joined the NYU Langone Vaccine Center and has since led multiple vaccine studies of COVID-19, Shingles, Influenza, Mpox, GBS, etc. During the pandemic, she was invited to multiple public events on vaccine education for the Latinx community next to important figures such Dr. Fauci, Dr. Demetre Daskalakis, Dr. Carlos del Rio, and Dr. David Chokshi (former NYC Health Commissioner). Dr. Kotkamp's recognition includes NYU Grossman School of Medicine Teacher of The Year award in 2021, IDCRC early career investigator of the year, and Fellow of the IDSA in 2024. Dr. Kottkamp is a former member of the Inclusion, Diversity, Equity & Access Committee of the Infectious Diseases Society of America, the Associate Director for Research and Diversity of the NYU Langone Vaccine Center and the Associate Program Director of the Infectious Disease and Immunology Fellowship Training Program at NYU Grossman School of Medicine.
Disclosure(s): No financial relationships to disclose
Thursday, October 17, 2024
5:05 PM – 5:20 PM US PT